
    
      Within strictly defined limits, the protocol permits the dose escalation committee to amend
      the dose escalation rules, doses proposed in the study protocol and to change the timing of
      or to add additional assessments following review of the safety, tolerability and plasma
      DS-1971a concentration data. The decisions to change the doses will be documented in the
      minutes of the dose escalation committee.
    
  